Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
Drug studies boost Vivus, Orexigen
Posted on April 04, 2011 at 11:38 AM EDT
Shares of Vivus and Orexigen Therapeutics are climbing on the release of favorable studies for their respective diet-drugs, both of which are up for FDA approval.
Read More >>
DFM BANK IND
Orexigen Therapeutics, Inc.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here